Formamide,N-[(1E,3R,4R,5R,9S,10S,11S)-10-hydroxy-11-[(1S,2'S,3S,5S,7R,8S,9R,12E,14E,16S,17R,19R)-16-hydroxy-3,5,7,17-tetramethoxy-8,14-dimethyl-11-oxospiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-9-yl]-4-methoxy-3,5,9-trimethyl-6-oxo-1-dodecen-1-yl]-N-methyl-,127999-44-4 Products Supply

Name: Formamide,N-[(1E,3R,4R,5R,9S,10S,11S)-10-hydroxy-11-[(1S,2'S,3S,5S,7R,8S,9R,12E,14E,16S,17R,19R)-16-hydroxy-3,5,7,17-tetramethoxy-8,14-dimethyl-11-oxospiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-9-yl]-4-methoxy-3,5,9-trimethyl-6-oxo-1-dodecen-1-yl]-N-methyl-
CAS NO.: 127999-44-4
Synonyms:
Formamide,N-[(1E,3R,4R,5R,9S,10S,11S)-10-hydroxy-11-[(1S,2'S,3S,5S,7R,8S,9R,12E,14E,16S,17R,19R)-16-hydroxy-3,5,7,17-tetramethoxy-8,14-dimethyl-11-oxospiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-9-yl]-4-methoxy-3,5,9-trimethyl-6-oxo-1-dodecenyl]-N-methyl-(9CI); Scytophycin B, 6-hydroxy-7-O-methyl-, (6S)-;Spiro[10,23-dioxabicyclo[17.3.1]tricosane-4,2'-oxirane], scytophycin B deriv.;Formamide,N-[10-hydroxy-11-(16-hydroxy-3,5,7,17-tetramethoxy-8,14-dimethyl-11-oxospiro[10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-triene-4,2'-oxiran]-9-yl)-4-methoxy-3,5,9-trimethyl-6-oxo-1-dodecenyl]-N-methyl-,[1S-[1R*,3R*,4R*,5R*,7S*,8R*,9S*(1E,3S*,4S*,5S*,9R*,10R*,11R*),12E,14E,16R*,17S*,19S*]]-;Tolytoxin; Tolytoxin A
Molecular Structure:
Molecular Formula: C46H75 N O13

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5S,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; 17-Oxa-1,4,7,23-tetraazabicycl; Formamide,N-[(1E,3R,4R,5R,9S,1; Formamide,N-[(1E,3R,4R,5R,9S,1; 10,23-Dioxabicyclo[17.3.1]tric; 1-Oxa-7-azaspiro[5.5]undecan-8; Formamide,N-[(1E,3R,4R,5R,9S,1; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C14H9Br2O2P/c15-11-6-8-13(17; 1/C18H19NO4/c1-22-15-8-11-10(7; 1/C16H15FN2O3S/c1-23(21,22)19-; 1/C19H15ClN2O2S/c1-11-19(23)24; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C18H18O6/c1-22-14-8-13(20)15; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C21H26N2O4/c1-3-14-8-9-19(25; 13H-12,16-Imino-2H,5H-pyrano[3; [(2S,3S,4R,6S)-6-[(2R,3S,4S,5R; 1/C19H24N2O2/c1-12(2)14-8-6-9-; 2-Butenoic acid,4-amino-4-oxo-; Formamide,N-[(1E,4R,5R,9S,10S,; 19-Oxa-1,4,7,25-tetraazabicycl; 2-Oxazolidinone,3-[(2R,3S,4S,7;